Transforming Eye Care with Ocular Oximetry

Structural imaging tools like OCT and fundus photography often detect disease too late—after damage is done. Yet conditions like glaucoma, diabetic retinopathy, and AMD are driven by earlier, invisible changes in metabolism and oxygenation. To catch these changes sooner, we need tools that look beyond structure.

This white paper explores ocular oximetry as a functional imaging approach, with a focus on tissue oxygen saturation (StO₂) as a key biomarker. It introduces Zilia’s targeted spectroscopy platform and highlights its potential to improve early detection, disease monitoring, and research into ocular and systemic health.

This Whitepaper covers:

• Why oxygen saturation is emerging as a critical early indicator in ocular disease.
• How spectroscopy enables real-time measurement of ocular tissue oxygenation.
• What recent research reveals about StO₂ patterns in glaucoma and diabetic retinopathy.